Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
ZPI Silencing as a Novel Non-Factor Therapy for Rare Bleeding Disorders – HITh
Nov 19, 2026, 05:20

ZPI Silencing as a Novel Non-Factor Therapy for Rare Bleeding Disorders – HITh

HITh lab Inserm, shared a post on LinkedIn about a recent article by Rim Hamze et al, published in Thromb Haemost, adding:

“Hot off the press!

Exciting new research in the field of rare bleeding disorders!

Today we celebrate our study, recently published in Thromb Haemost Thrombosis Haemostasis!

We explored an innovative non-factor therapeutic approach: targeting Protein Z-dependent protease inhibitor (ZPI) using a GalNAc-conjugated small interfering RNA (mTGM-148) from Tangram Therapeutics, in our murine models of vonWillebrandDisease and FX deficiency.

siRNA-mediated reduction of ZPI levels was associated with enhanced thrombin generation and clotting parameters, as well as improved hemostasis in bleeding assays.

These results show that ZPI inhibition represents a promising non-factor therapeutic approach for selected rare bleeding disorders!

Congratulations to all involved co-authors!”

Title: Small Interfering RNA Targeting Protein Z-Dependent Protease Inhibitor Improves Hemostasis in Von Willebrand Factor- and Factor X-Deficient Mice

Authors: Rim Hamze, Mariem Khamari, Kaitlyn R Calabro, Antoine Jehl, Christine Becker, Alexandre J Debacker, Natalie W Prusell, Damian Elle, Lijuan Pang, Ya Sun, Qian Wang, Qiugang Lei, Song Chen, Alice Guérin, Geneviève McCluskey, Caterina Casari, Elsa P Bianchini, Olivier D Christophe, Alan V Whitmore, Peter J Lenting, Cécile V Denis

ZPI Silencing as a Novel Non-Factor Therapy for Rare Bleeding Disorders - HITh

Stay updated on all scientific advances with Hemostasis Today.